Nucala 100 MG/ML auto-injectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FQJW2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,386
Award facts
- Contract value 100% obligated
- $17,386.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,386.47 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for NUCALA 100 mg/mL auto-injector units. The delivery order, issued on January 16, 2026, with an ultimate completion date of January 20, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award was issued without subcontractors and represents a routine fulfillment under the company's existing pharmaceutical supply relationship with the federal government.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to ensure reliable pharmaceutical supply to Department of Defense military healthcare facilities worldwide. The underlying indefinite delivery contract, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, with a completion date of December 31, 2036. As an authorized prime vendor under this program, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceuticals, biologics, and medical consumables to support recurring medical supply needs across the military healthcare system globally.
Quick answers
Who was awarded contract SPE2DR26FQJW2?
SPE2DR26FQJW2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FQJW2 worth?
The government has obligated $17,386 on SPE2DR26FQJW2.
Is contract SPE2DR26FQJW2 an order under another contract?
Yes. SPE2DR26FQJW2 is a delivery order under SPE2DR25D9135, an indefinite delivery contract.
Was contract SPE2DR26FQJW2 competed?
The extent of competition for SPE2DR26FQJW2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award